Pinnacle Financial Partners Inc Abbott Laboratories Transaction History

Pinnacle Financial Partners Inc

  • $4.92 Billion
  • Q3 2024

A detailed history of Pinnacle Financial Partners Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 51,094 shares of ABT stock, worth $6.53 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
51,094
Previous 48,004 6.44%
Holding current value
$6.53 Million
Previous $4.99 Million 16.78%
% of portfolio
0.12%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$100.07 - $118.13 $309,216 - $365,021
3,090 Added 6.44%
51,094 $5.83 Million
Q2 2024

Aug 06, 2024
SELL
$100.73 - $112.44 $43,616 - $48,686
-433 Reduced 0.89%
48,004 $4.99 Million
Q1 2024

Apr 30, 2024
BUY
$109.52 - $120.96 $38,551 - $42,577
352 Added 0.73%
48,437 $5.51 Million
Q4 2023

Jan 22, 2024
SELL
$90.19 - $110.4 $300,062 - $367,300
-3,327 Reduced 6.47%
48,085 $5.29 Million
Q3 2023

Nov 03, 2023
SELL
$95.53 - $114.62 $241,881 - $290,217
-2,532 Reduced 4.69%
51,412 $4.98 Million
Q2 2023

Aug 07, 2023
BUY
$100.78 - $112.29 $148,247 - $165,178
1,471 Added 2.8%
53,944 $5.88 Million
Q1 2023

Apr 26, 2023
BUY
$96.86 - $114.01 $86,786 - $102,152
896 Added 1.74%
52,473 $5.31 Million
Q4 2022

Feb 03, 2023
SELL
$95.06 - $111.52 $1.85 Million - $2.17 Million
-19,425 Reduced 27.36%
51,577 $5.66 Million
Q3 2022

Oct 31, 2022
BUY
$96.76 - $112.03 $1.59 Million - $1.85 Million
16,480 Added 30.23%
71,002 $6.87 Million
Q2 2022

Jul 29, 2022
SELL
$102.07 - $123.37 $146,878 - $177,529
-1,439 Reduced 2.57%
54,522 $5.92 Million
Q1 2022

May 02, 2022
BUY
$114.02 - $139.04 $160,654 - $195,907
1,409 Added 2.58%
55,961 $6.62 Million
Q4 2021

Feb 01, 2022
BUY
$115.53 - $141.46 $231,868 - $283,910
2,007 Added 3.82%
54,552 $7.68 Million
Q3 2021

Oct 26, 2021
BUY
$116.66 - $129.06 $27,648 - $30,587
237 Added 0.45%
52,545 $6.21 Million
Q2 2021

Jul 21, 2021
BUY
$105.79 - $124.53 $199,625 - $234,988
1,887 Added 3.74%
52,308 $6.06 Million
Q1 2021

Apr 19, 2021
SELL
$108.84 - $128.23 $101,330 - $119,382
-931 Reduced 1.81%
50,421 $6.04 Million
Q4 2020

Jan 13, 2021
SELL
$105.0 - $114.42 $315 - $343
-3 Reduced 0.01%
51,352 $5.62 Million
Q3 2020

Oct 27, 2020
SELL
$91.64 - $111.29 $25,292 - $30,716
-276 Reduced 0.53%
51,355 $5.59 Million
Q2 2020

Jul 28, 2020
SELL
$76.57 - $98.0 $43,568 - $55,762
-569 Reduced 1.09%
51,631 $4.72 Million
Q1 2020

Apr 16, 2020
SELL
$62.82 - $91.86 $25,379 - $37,111
-404 Reduced 0.77%
52,200 $4.12 Million
Q4 2019

Feb 06, 2020
SELL
$78.51 - $87.4 $37,841 - $42,126
-482 Reduced 0.91%
52,604 $4.57 Million
Q3 2019

Oct 25, 2019
BUY
$81.84 - $88.74 $161,388 - $174,995
1,972 Added 3.86%
53,086 $4.44 Million
Q2 2019

Aug 13, 2019
BUY
$72.88 - $85.0 $30,828 - $35,955
423 Added 0.83%
51,114 $4.3 Million
Q1 2019

May 02, 2019
SELL
$66.22 - $80.06 $38,937 - $47,075
-588 Reduced 1.15%
50,691 $4.05 Million
Q4 2018

Feb 04, 2019
BUY
$65.56 - $74.27 $48,776 - $55,256
744 Added 1.47%
51,279 $3.71 Million
Q3 2018

Oct 31, 2018
BUY
$60.81 - $73.36 $49,803 - $60,081
819 Added 1.65%
50,535 $3.71 Million
Q2 2018

Jul 27, 2018
BUY
$57.57 - $63.54 $147,839 - $163,170
2,568 Added 5.45%
49,716 $3.03 Million
Q1 2018

May 03, 2018
BUY
$56.27 - $63.62 $16,318 - $18,449
290 Added 0.62%
47,148 $2.83 Million
Q4 2017

Feb 08, 2018
SELL
$53.68 - $57.47 $54,485 - $58,332
-1,015 Reduced 2.12%
46,858 $2.67 Million
Q3 2017

Nov 08, 2017
BUY
$48.06 - $53.64 $2.3 Million - $2.57 Million
47,873
47,873 $2.55 Million

Others Institutions Holding ABT

# of Institutions
3,208
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Pinnacle Financial Partners Inc Portfolio

Follow Pinnacle Financial Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email